Literature DB >> 362722

The pathophysiology and clinical aspects of hypercalcemic disorders.

D B Lee, E T Zawada, C R Kleeman.   

Abstract

FOR THE PURPOSES OF THIS REVIEW, THE VAST AND INCREASINGLY COMPLEX SUBJECT OF HYPERCALCEMIC DISORDERS CAN BE BROKEN DOWN INTO THE FOLLOWING CATEGORIES: (1) Physiochemical state of calcium in circulation. (2) Pathophysiological basis of hypercalcemia. (3) Causes of hypercalcemia encountered in clinical practice: causes indicated by experience at the University of California, Los Angeles; neoplasia; hyperparathyroidism; nonparathyroid endocrinopathies; pharmacological agents; possible increased sensitivity to vitamin D; miscellaneous causes. (4) Clinical manifestations and diagnostic considerations of hypercalcemic disorders. (5) The management of hypercalcemic disorders: general measures; measures for lowering serum calcium concentration; measures for correcting primary causes-the management of asymptomatic hyperparathyroidism.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 362722      PMCID： PMC1238350     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


  499 in total

1.  Selective arteriography, venography and venous hormone assay in diagnosis and localization of parathyroid lesions.

Authors:  H Eisenberg; J Pallotta; L M Sherwood
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

2.  Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.

Authors:  H D Brereton; P V Halushka; R W Alexander; D M Mason; H R Keiser; V T DeVita
Journal:  N Engl J Med       Date:  1974-06-11       Impact factor: 91.245

3.  Treatment of primary hyperparathyroidism.

Authors:  D C Purnell; D A Scholz; L H Smith; G W Sizemore; M B Black; R S Goldsmith; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

4.  Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease.

Authors:  R C Benson; B L Riggs; B M Pickard; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

5.  Bone-resorbing activity in supernatants from lymphoid cell lines.

Authors:  G R Mundy; R A Luben; L G Raisz; J J Oppenheim; D N Buell
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

6.  Magnitude of metabolic acidosis in primary hyperparathyroidism.

Authors:  F L Coe
Journal:  Arch Intern Med       Date:  1974-08

7.  Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites.

Authors:  R M Russell; J L Boyer; S A Bagheri; Z Hruban
Journal:  N Engl J Med       Date:  1974-08-29       Impact factor: 91.245

8.  Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism.

Authors:  R C Benson; B L Riggs; B M Pickard; C D Arnaud
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

9.  Hypervitaminosis A and congenital renal anomalies in a human infant.

Authors:  I B Bernhardt; D J Dorsey
Journal:  Obstet Gynecol       Date:  1974-05       Impact factor: 7.661

10.  Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.

Authors:  R A Luben; G R Mundy; C L Trummel; L G Raisz
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808
View more
  3 in total

Review 1.  Fasting: the history, pathophysiology and complications.

Authors:  P R Kerndt; J L Naughton; C E Driscoll; D A Loxterkamp
Journal:  West J Med       Date:  1982-11

2.  Management of severe hypercalcaemia.

Authors: 
Journal:  Br Med J       Date:  1980-01-26

Review 3.  Paraneoplastic syndromes.

Authors:  D C Stolinsky
Journal:  West J Med       Date:  1980-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.